Profit Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,306	Closed	-$323K	–	79
2023 Q4	$323K	Hold	10,306	–	–	0.18%	75
2023 Q3	$215K	Sell	10,306 -523	-5%	-$14.2K	0.15%	72
2023 Q2	$259K	Sell	10,829 -179	-2%	-$3.98K	0.17%	73
2023 Q1	$207K	Hold	11,008	–	–	0.14%	75
2022 Q4	$175K	Hold	11,008	–	–	0.12%	75
2022 Q3	$180K	Hold	11,008	–	–	0.14%	77
2022 Q2	$155K	Sell	11,008 -2,508	-19%	-$46.8K	0.11%	78
2022 Q1	$328K	Buy	13,516 +1,844	+16%	+$44.6K	0.2%	74
2021 Q4	$273K	Sell	11,672 -500	-4%	-$10.1K	0.17%	79
2021 Q3	$203K	Hold	12,172	–	–	0.14%	86
2021 Q2	$295K	Hold	12,172	–	–	0.16%	81
2021 Q1	$314K	Hold	12,172	–	–	0.18%	78
2020 Q4	$651K	Sell	12,172 -9,749	-44%	-$484K	0.42%	49
2020 Q3	$905K	Buy	+21,921	New	+$947K	0.56%	64